Signal active
Organization
Contact Information
Overview
Founded in March 2012 in partnership with the Medical College of Wisconsin, Somna Therapeutics is a medical device company focused on improving the quality of life for the millions of people suffering from laryngopharyngeal reflux (LPR) / extraesophageal acid reflux disease (EERD). The Reza Band™, UES Assist Device is designed to be a non-invasive solution. In the near-term, Somna Therapeutics is planning to optimize product design and complete clinical trials to gain FDA clearance. We anticipate upon FDA clearance and product launch, to be selling to hospitals, physician clinics, and home health care.
About
Health Care, Medical, Clinical Trials
2012
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Somna Therapeutics headquartered in United States, North America, operates in the Health Care, Medical, Clinical Trials sector. The company focuses on Health Care and has secured $737.9M in funding across 84 round(s). With a team of 11-50 employees, Somna Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Angel Round - Somna Therapeutics, raised $700.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
7
1
0
$8.8M
Details
5
Somna Therapeutics has raised a total of $8.8M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2015 | Seed | 2.0M | ||
2015 | Seed | 995.3K | ||
2018 | Late Stage Venture | 1.7M | ||
2014 | Seed | 700.0K |
Investors
Somna Therapeutics is funded by 10 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Somna Therapeutics | - | FUNDING ROUND - Somna Therapeutics | 1.7M |
Somna Therapeutics | - | FUNDING ROUND - Somna Therapeutics | 1.7M |
Somna Therapeutics | - | FUNDING ROUND - Somna Therapeutics | 700.0K |
Jeff Rusinow | - | FUNDING ROUND - Jeff Rusinow | 700.0K |
Recent Activity
There is no recent news or activity for this profile.